Objective To develop a statistical model generating utility estimates for prostate cancer specific health states, using preference weights derived from the perspectives of prostate cancer patients, men at risk for prostate cancer, and society. Methods Utility estimate values were calculated using standard gamble (SG) methodology. Study participants valued 18 prostate-specific health states with the five attributes: sexual function, urinary function, bowel function, pain, and emotional well-being. Appropriateness of model (linear regression, mixed effects, or generalized estimating equation) to generate prostate cancer utility estimates was determined by paired t-tests to compare observed and predicted values. Mixed-corrected standard SG utility estimates to account for loss aversion were calculated based on prospect theory. Results 132 study participants assigned values to the health states (n = 40 men at risk for prostate cancer; n = 43 men with prostate cancer; n = 49 general population). In total, 792 valuations were elicited (six health states for each 132 participants). The most appropriate model for the classification system was a mixed effects model; correlations between the mean observed and predicted utility estimates were greater than 0.80 for each perspective. Conclusions Developing a health-state classification system with preference weights for three different perspectives demonstrates the relative importance of main effects between populations. The predicted values for men with prostate cancer support the hypothesis that patients experiencing the disease state assign higher utility estimates to health states and there is a difference in valuations made by patients and the general population.
Introduction
Preference weights, or utility estimates, are necessary components of cost-utility analyses (CUA) and for calculating quality-adjusted life-year (QALY) estimates. CUA originates in constrained optimization; it is used as an index of benefit that can inform resource allocation decisions across a range of disease areas and therapeutic interventions that also use the QALY [1] . The United Kingdom National Institute for Health and Care Excellence (NICE) issued a guidance stating preference for economic evaluations using generic preference-based utility measures, specifically the EuroQol EQ-5D [2] . Utility estimates for men with prostate cancer have been obtained using the EQ-5D. The EQ-5D demonstrated good agreement with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) and was used to estimate the impact of treatment related adverse events [3, 4] . The EQ-5D is an acceptable measure for generic health-related quality of life [HRQoL] utility estimates for CUA, but ceiling effects have been reported indicating that it may not always be sensitive enough for specific disease states and more appropriate for health of populations with more morbidity [5] . An alternative method for obtaining preference-based utility estimates includes the use of direct elicitation based on expected utility theory [6] . The standard gamble (SG), a direct elicitation method, satisfies the four axioms of expected utility theory.
Utility estimates informing the QALY index are measured on an interval scale between 0 and 1, where the scale anchors represent dead (value of 0) and full health (value of 1.0), respectively [7] . Mean utility estimates vary according to perspective (patients or members of the general population) and elicitation method (standard gamble, time trade off, or rating scale). Studies have shown that patients rate their own health states higher than the general population rating the same states [8, 9] . Differences may arise because patients have adapted to their condition or because the general population overestimates the impact of disability or disease on quality of life (i.e., exhibit loss aversion) [8, 9] . Utility estimates for outcomes in prostate cancer are of unique importance since generic measures do not represent prostate cancer outcomes such as sexual, urinary, and bowel dysfunction well and may not capture their full impact [10] .
Policymakers may allocate scarce resources on the basis of a CUA, so it is important that the values obtained for these assessments are consistent for comparison purposes [11] . Health economists typically obtain utility estimates for use in CUA from the societal perspective, as supported by extra-welfarist theory, as the societal perspective allows for those contributing financially to society to have their preferences reflected. Extra-welfarists theory is grounded in the belief that the post-illness preference would result in the provision of marginally beneficial care and are subject to change and adaptation [12] . To understand the potential difference between patient and societal perspectives, a classification system for prostate cancer-specific health states were valued by three perspectives. The objective of this study was to use the preference weights of 18 health states to generate a model that can be used to predict preference weights for all 243 health states for populationbased preference weights, patient-based preference weights, and a third unique perspective, men at risk for prostate cancer.
Methods
The target study population included 40 men at risk for prostate cancer, 40 men with prostate cancer, and 40 participants from the general population in the Western Washington region (King, Kitsap, Pierce, and Snohomish counties) in the USA recruited from July 2013 through March 2014. Men at risk for prostate cancer were recruited from the University of Washington Medical Center. Eligible participants were 45-70 years of age, had a prostate specific antigen value (PSA) C2.6 ng/ml, and had no diagnosis of prostate cancer. Men with prostate cancer were recruited from the Cancer Surveillance System (CSS), at the Fred Hutchinson Cancer Research Center (FHCRC). Eligible participants were 45-70 years of age, had a histological confirmed diagnosis of prostate cancer within the past 3 years, and had self-reported experience with prostate cancer symptoms. The general population was recruited from the Washington State Department of Licensing Database. Eligible participants were 18-70 years of age and did not have a diagnosis of prostate cancer. All participants were required to complete the interview in person, be willing and able to given written informed consent, and speak and read English. The study protocol and consent form were submitted and approved by the FHCRC and the University of Washington institutional review board.
The health states were developed based on a review of three different sources: (1) previously developed patient reported outcome (PRO) measures in prostate cancer, generic PRO measures validated in patients with prostate cancer, and previous health states used for prostate cancer preference elicitation measures, (2) qualitative research conducted in patients with prostate cancer, and (3) a review of an online patient forum to gain an understanding of the most commonly reported symptoms directly from patients with prostate cancer (details provided in Appendix A).
From the list of potential attributes five were selected based on the following criteria: frequency of attributes reported in the literature, the most common symptoms reported on the patient forum, and feasibility of including the attribute in a preference elicitation study based on the opinion of the study team. The prostate cancer-specific attributes in the health states were sexual functioning, urinary functioning, bowel functioning, pain, and fear of the future ( Table 1) .
The descriptive system includes 243 health states, and valuations were obtained for 18 of the health states selected using an orthogonal experimental design generated in SAS statistical programing package. Each participant was randomly assigned to one of three experimental design blocks to value a total of six health states ( Table 2 ). Valuation of the six health states was done using standard gamble (SG) methods [13] . A SG board was used to present two choices to the participants ''for the rest of your life'' and probability p was varied (increments of 10 %) until the participant was indifferent between choices. In addition to collecting the disease-specific utility estimates, data were collected on age, gender, living situation, marital status, employment, education level, racial/ethnic background, and concomitant medical conditions for the study participants. Participants were also asked if they considered themselves to be religious and if they have a trusting relationship with their physician (Study Questionnaire Provided in Appendix B). Demographic characteristics such as age, education, gender, religion, race, and marital status were important covariates to collect given their potential influence on preference valuations [14] [15] [16] [17] [18] .
Statistical Analysis

Model Development
A number of different models were investigated to determine the appropriate fit for estimating SG values: linear regression, mixed effects model, and generalized estimating equations (GEE) [19] [20] [21] . Model 1 was a least squares linear regression, accounting for within-individual clustering, and assuming a standard zero mean, constant variance error structure, and independent error terms. Model 2 was a mixed effects model accounting for both within and between individual error components. Models 3 and 4 were GEE models with a gamma distribution in two different functional forms (log link and power link). The GEE model estimates within-cluster similarity of the residuals and uses the estimated correlation to re-estimate the regression parameters and to calculate standard errors [19] [20] [21] . To account for heteroscedasticity, Huber-White standard errors were applied [22] . Comparison of models to determine the best fit was assessed based on inconsistencies in regression coefficients, the number of significant coefficients, and comparison of observed and predicted values. As the severity of the level increases, it is expected that there would be greater disutility of the attribute so an inconsistency would be less disutility with greater severity of the attribute. Paired t-tests were used to compare observed and predicted values and the correlation between the observed and predicted was calculated and plotted. 
Variables
The dependent variable was SG utility estimate; a continuous variable ranging from 0 (dead) to 1.0 (perfect health). Independent variables included the main effects from the health-state classification system. The least severe level in each health-state attribute was coded as the reference variable so two dummy variables were included for each health state: sexual function (S2, S3), urinary function (U2, U3), bowel function (B2, B3), pain (P2, P3), and fear of the future (F2, F3). Age, education, gender, religion, race, and marital status were included as covariates in the model.
Results
A total of 132 participants completed the SG valuation exercise (n = 40 men at risk for prostate cancer; n = 43 men with prostate cancer; n = 49 men and women from the general population). Not surprisingly, men with prostate cancer were statistically different from the general population in terms of age, gender, employment status, and relationship status testing for group comparison of means (Table 3 ). In total, 792 health-state valuations were elicited (six health states for each 132 participants). The mean SG value was 0.64 (SD 0.235), median value was 0.65 (range 0-1.0), and the mean SG for each health state by study group is presented in Table 2 .
Valuation Model
The appropriate modeling strategy was not clear a-priori, without first examining the distribution of the valuation data. The SG health-state values were skewed towards 1.0, contributing to the choice of model. In addition, the health-state values were likely to be clustered by participant. Individuals did not value the same set of states, although allocation of states to individuals was random, the differences between health-state values may be due to differences in preferences of the individuals, rather than the attributes of those states [19] . Table 4 provides the parameter estimates of four different models for the estimation of SG utility estimates. While age and gender were not found to be statistically significantly different from no effect on SG utility estimates, they were retained because prostate cancer is age and gender dependent. Education, marital status, and race were retained based on the statistical significance of the parameter estimates. The most appropriate model was determined to be the mixed effects model based on comparisons between observed and predicted health-state valuations (Fig. 1) . There were no statistically significant differences between the observed and predicted values in the men at risk for prostate cancer group and the men with prostate group, correlations between groups were greater than 0.80 (men at risk for prostate cancer r = 0.80; men with prostate cancer r = 0.92; general population r = 0.84). For the general population group there were three health states (22311; 12231; 33331) with a predicted value significantly different than the observed value. Model fit was also determined by inconsistencies in regression coefficients and the number of significant coefficients. The main effects (sexual functioning levels, urinary functioning levels, bowel functioning levels, pain level, and fear of the future levels) were expected to be negative and increasing in absolute size from level 2 to level 3. An inconsistent result occurs where a coefficient on the main effects decreases in absolute size for a worse level (level 3 coded as the worst level) [19] . In all four models there were inconsistencies in the Fear of the Future attribute with level two having a positive coefficient. A positive coefficient was observed in the Bowel Function attribute in the GEE model with a power link function. The number of significant coefficients for the main effects was similar Living condition, n (%) P \ 0. between the mixed effects model and the two different GEE models (seven significant coefficients). The final model parameter estimates, for the fitted mixed effects model, for total sample and each perspective is presented in Table 5 . The gender variable was omitted in both the men at risk for prostate cancer and the men with prostate cancer groups given that only men are included in these samples. The final model allows for estimating all 243 possible health-state combinations using individual level data to populate the independent variables in the model. Comparing the main effects, the sexual function attribute level 2 was statistically significant different from zero for the general population group but not for the men at risk for prostate cancer or men with prostate cancer. This indicates that older men faced with prostate cancer place less emphasis on sexual functioning compared to the general population. Moderate bowel function was not statistically significant from zero for all groups, indicating no difference between no bowel dysfunction and moderate bowel dysfunction in valuing health states. A similar observation was seen with urinary function level 2 for the general population group; but men at risk for or with prostate cancer differentiated between no urinary dysfunction and moderate urinary dysfunction. There was no 
Discussion
Preference weights for 18 health states were used to generate a model that can be used to predict utility estimates for all 243 possible health states in a prostate specific health-state classification system. The importance of developing a classification system for each perspective was based on the foundation that patients adapt to their disease state causing an inflation of values, but members of the public may not be able to fully understand the experience of living with a disease or be able to imagine how their life might change in its presence [23] . This study contributes to the current body of research by providing utility estimates for prostate cancer specific health states. But this study is the first to create different classification systems for different perspectives using the same prostate cancer health states to provide researchers with an understanding on how perspective may influence utility estimates. Interpretation of the results is dependent upon the selection of the final model and the assumptions within the statistical boundaries of the selected methods. The two most common statistical models for examining an association between a predictor of interest and a continuous outcome variable in data with clustering are GEE and mixed-effects linear regression models [24] . GEE models the marginal distribution of repeated observed outcomes as a function of risk factors while accounting for the dependence of the repeated outcome variable by assuming a certain working correlation structure [20, 21] . The mixed effects linear regression model allows the intercept or the regression coefficients or both to vary between subjects [20, 21] . Standard goodness of fit statistics, such as R 2 , AIC and BIC, cannot be done on GEE models limiting the ability to compare between models when determining the most appropriate. Given the similarities between the mixed effects model and GEE, the final model was selected based on the scientific question and comparison of the observed valuations and predicted valuations.
The mixed-effects linear regression model allows for an assessment of the between subject and within subject effects, but the estimates may be biased if the distribution is missspecified [23] . Additional investigation into the appropriate data transformation could be warranted but was not pursued given the authors' interest in maintaining the integrity of the distribution of the data and interpretation of utility estimate on a zero to 1.0 scale [23] . The constant coefficient in Model 4 (GEE with power link) was greater than 1.0 (c = 1.0840). The constant coefficient is the outcome value (utility estimate) when all of the independent variables are set to 1.0. If all of the health-state attributes were set to 1.0 then we would be modeling health state 11111, which is anchored at perfect health and a utility estimate greater than 1.0 is not possible. This model includes the following covariates: age, gender, race, education, and marital status, which complicates the interpretation of the constant term as all of those parameters would need to be set to the reference value. To benchmark interpretation of the results, the next step would be to determine a scaling term so that a utility estimate greater than 1.0 is not a possible outcome. Fig. 1 Association between observed and predicted health state values using the mixed effects model Available evidence suggests that experience of illness may influence respondent's valuations of health states; patients with a particular condition often assign a higher utility than do patients without the condition [25] . There was a clear difference in the valuations of the sexual function attribute when comparing the general population group with men at risk for prostate cancer and men with prostate cancer. The difference between levels was only significant for the general population group, which may be attributable to the difference in age between the groups. The general population group included men and women 18-70 years old, where the other two groups were inclusive of men 45-70 years old. Another hypothesized reason for this observation may be the inclusion of women in the general population group placing value on a health state describing men's sexual functioning.
Another notable difference between study groups was the lack of significance comparing moderate pain with no pain in the men with prostate cancer population. Men with prostate cancer experience pain as part of their disease state and as a common side effect of treatments. The general population and men at risk for prostate cancer could be imagining a pain level that does not align with that experienced by the men with prostate cancer causing the difference between groups. The third notable finding when comparing main effects between groups was the lack of statistical significance for fear of the future level 3 in men at risk for prostate cancer. This contradicts our hypothesis that being faced with the risk of disease would have a profound impact on emotional well-being. Of course, this may be a phenomenon of sample size and a larger sample and the valuation of additional health states may have overcome these discrepancies. The inconsistencies in the coefficient (positive value when it should be negative) observed in sexual function level 2, bowel function level 2, and fear of the future level 2 would need to be reexamined with a larger sample size to understand if the observation is model dependent and could be further explored in samples with similar ages. An interesting finding when comparing the predicted health-state valuations to the observed valuations for each study population was the similarities between the predicted values for men at risk for prostate cancer and the general population. Not only were several of the individual health states predicted to have the same value but the range is the same (0.44 for the lowest health state: 33331 and 0.82 for greatest health state: 11212). These results imply that a member of the general population may value prostate cancer specific health states similarly to men at risk for developing prostate cancer. The predicted values for men with prostate cancer support the hypothesis that patients experiencing the disease state assign higher utility estimates to health states and valuations made by patients differ from valuations made by the general population.
The societal perspective included both men and women evaluating male-specific health states for prostate cancer. Women were included to represent the societal perspective. An ad hoc analysis was conducted to explore the difference in gender within the general population group. The mean preference weights for men in the general population group (n = 21) ranged from 0.27 to 0.91 compared to the mean preference weights for females (n = 28), which ranged from 0.36 to 0.77. In general, male respondents placed higher valuations on the more desirable health states and the females place higher valuations on the less desirable health state. There was a statistically significant difference between men and women in only one health state, the most desirable health state, with the men rating the state higher than the females (p \ 0.05). The influence of perspective for breast cancer specific health states was investigated comparing women with breast cancer, general practitioners, university staff, nurses, and hospital doctors [26] . In addition to finding that women with breast cancer rated health states higher (more desirable) compared to those with no direct experience with breast cancer, they found no statistically significant difference in preference weights comparing female breast cancer patients with males. Similarly a time trade-off study to determine utility values for erectile dysfunction from the societal perspective interviewed women who were instructed to image being a man with erectile dysfunction when responding to the questions and found no difference between the values of men and women [27] .
The study results should be interpreted within the context of limitations. The strength of the statistical model and significance of parameters would be enhanced by an increase in the sample size for each group. The sample size was based on the one-sided hypothesis that the general population preference values will be lower than the patient preference values [13] . A sample size to detect this difference was approximately 40-50 participants in each group. A total of 40-50 participants per group were enrolled in the study but after determination of the sample size the study team decided to reduce the burden on the study participants. Because of the number of health states in the classification system, study participants did not value all 18 health states, but a sample of six health states, and this reduced the power. Ideally and to improve the power participants would have had to value all 18 health states. Fitting data to a model is a combination of decision making based on model fitting statistics and decision making based on the research question. Non-significant covariates were retained in the model based on the importance of the parameters for prostate cancer, but one may decide to remove those covariates based on statistical considerations, in which case the final model coefficients may change. The study results are generalizable to the Western Washington region. Recruitment was designed to obtain a random sample within the constraints of the sampling frame, but valuations made from those in the Western Washington should not be extrapolated to a national sample, without first comparing the demographics of the sample.
The use of a disease-specific classification system to improve specificity in utility estimates for those experiencing the disease state needs to be considered against losing generalizability for comparison of results to other disease states for benchmarking purposes. Developing the health-state classification system with preference weights for three different perspectives demonstrates the relative importance of main effects between populations and highlights the accuracy in a disease-specific measure. The predicted values for men with prostate cancer support the hypothesis that patients experiencing the disease state assign higher utility estimates to health states and there is a difference in valuations made by patients and the general population. But the results should be interpreted within the constraints of the study and awareness needs to be called attention to when using disease-specific health states that limit the comparison of health changes in prostate cancer with QALY changes in other conditions. This trade-off between accuracy and generalizability has a profound impact in health economics research and the objective and use of the CUA for prostate cancer should guide the selection of perspective while understanding the implications.
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